Effective Treatment for ME

M.E – Myalgic Encephalomyelitis

M.E stands for Myalgic Encephalomyelitis or perhaps more correctly Myalgic Encephalomyelopathy.

Contact Gill to

Book a FREE 30 minute
phone consultation
 

Email Gill Here:

gill@gillgoughtherapy.co.uk

T: 07920 179 131

Mickel Therapy believes that M.E, CFS and Fibromyalgia are all caused by a dysfunction of the Hypothalamus that Dr Mickel has dubbed ‘Hypothalamitis’. This is a broad spectrum of illness with many shared symptoms and degrees of severity. Please note this is a hypothesis only and not backed by scientific research as yet. Similarly the results have not yet been independently studied and are based on client testimony only until the trial of Mickel Therapy is complete and published.

The term M.E is not universally recognised or used worldwide and most areas now refer to cases as having Chronic Fatigue Syndrome. M.E as a term is partly correct. The ‘Mylagic’ purely means painful muscles and as most sufferers of M.E will know this can be extreme. The ‘encephalomyelitis’ however suggests inflammation of the brain and studies fail to prove this in M.E cases and it is really a misnomer.

Much research goes into M.E. This involves looking for viral clues or other infective causes. Some of the most commonly suggested causes are that M.E is due to an unknown virus, Borrelia or Lyme’s Disease, Epstein Barr infection (Glandular Fever), adrenal ‘burnout’ or Candida. Mickel Therapy has consistently treated successfully many cases of M.E who were given the above as causes. This suggests that they are incorrect and further study of such pathogens is a waste of resources.

Please note that Mickel Therapy's results are based on client testimony and have not yet been backed up by research. The latter is in place and results will be disseminated when the study is complete.

Through his experiences in treating M.E over the last 10 years Dr Mickel believes strongly that the causes suggested above are inaccurate and if they do exist then they are inconsequential effects of the state of dysfunction in the Hypothalamus (‘Hypothalamitis’). The latter being his hypothesis and is not yet backed by scientific research. The fact that the clients (with cases of M.E) claim that Mickel Therapy has treated them successfully and did not involve any attention to these suggested problems, even if tests showed they had been present, suggests that the case for them being causes must be in doubt.

Mickel Therapy is hopeful to prove this point once and for all through the planned Clinical Trials into its work on M.E, Chronic Fatigue Syndrome and Fibromyalgia.